Tokyo, Nov. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059588) titled 'Effects of Different Flow Rates in High-Flow Nasal Cannula Oxygen Therapy on Exercise Tolerance' on Nov. 1.
Study Type:
Interventional
Study Design:
Basic Design - Cross-over
Randomization - Randomized
Blinding - Single blind -participants are blinded
Control - Dose comparison
Primary Sponsor:
Institute - Nagasaki University
Condition:
Condition - healthy adults
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To investigate the effects of different gas flow rates in HFNC therapy on exercise tolerance
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - High-Flow Nasal Cannula Oxygen Therapy Settings: FiO2 0.21, Flow 30 L/min
Interventions/Control_2 - High-Flow Nasal Cannula Oxygen Therapy Settings: FiO2 0.21, Flow 45 L/min
Eligibility:
Age-lower limit - 18
years-old
Gender - Male
Key inclusion criteria - Young healthy males who understood the purpose of this study and provided informed consent
Key exclusion criteria - Individuals for whom cardiopulmonary exercise testing is difficult due to musculoskeletal disorders or lower limb pain
Individuals with a history of respiratory or cardiovascular disease
Individuals who have smoked within the past month
Target Size - 20
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2025 Year 06 Month 09 Day
Date of IRB - 2025 Year 06 Month 25 Day
Anticipated trial start date - 2025 Year 07 Month 01 Day
Last follow-up date - 2025 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068151
Disclaimer: Curated by HT Syndication.
